Abstract
Aim: To discuss available information on the opportunity for pregnant women affected by diabetes/obesity to receive COVID-19 vaccine.
Data synthesis: Pregnant women with SARS-CoV-2 (COVID-19) infection are at high risk for severe acute respiratory syndrome and adverse outcomes. Pregnant women with severe COVID-19 present increased rates of preterm delivery (<37 gestational weeks), cesarean delivery and neonatal admissions to the intensive care unit. Comorbidity such as diabetes (pregestational or gestational) or obesity further increased maternal and fetal complications. It is known that diabetic or obese patients with COVID-19 present an unfavorable course and a worse prognosis, with a direct association between worse outcome and suboptimal glycol-metabolic control or body mass index (BMI) levels. Critical COVID-19 infection prevention is important for both mother and fetus. Vaccination during pregnancy is a common practice. Vaccines against COVID-19 are distributed across the world with some population considered to have a priority. Since pregnant women are excluded from clinical trials very little information are available on safety and efficacy of COVD-19 vaccines during pregnancy. However, it is well known the concept of passive immunization of the newborn obtained with transplacental passage of protective antibodies into the fetal/neonatal circulation after maternal infection or vaccination. Moreover, it has been reported that COVID-19 vaccine-induced IgG pass to the neonates through breastmilk. Therefore, maternal vaccination can protect mother, fetus and baby.
Conclusions: After an individual risk/benefit evaluation pregnant and lactating women should be counselled to receive COVID-19 vaccines.
Keywords: COVID-19; Diabetes mellitus type 1; Diabetes mellitus type 2; Gestational diabetes; Pregnancy; Vaccines.
【저자키워드】 COVID-19, Vaccines., Pregnancy, Diabetes mellitus type 1, Diabetes mellitus type 2, Gestational diabetes, 【초록키워드】 passive immunization, SARS-CoV-2, IgG, Efficacy, Vaccine, COVID-19 vaccine, vaccination, clinical trial, intensive care, severe COVID-19, obesity, Infection, Diabetes Mellitus, intensive care unit, clinical trials, Comorbidity, diabetes, outcome, immunization, adverse outcomes, pregnant women, Severe acute respiratory syndrome, COVID-19 vaccines, Newborn, body mass index, Pregnancy, Neonate, Neonates, protective antibodies, COVID-19 infection, Infection prevention, complications, fetus, breastmilk, women, circulation, BMI, respiratory, information, Admission, Protective antibody, baby, mother, Diabetes mellitus type 2, Gestational diabetes, association, pregnant, COVD-19, Neonatal, high risk, during pregnancy, preterm delivery, direct association, transplacental passage, body mass, glycol, Diabetic, acute respiratory syndrome, obese, priority, worse prognosis, lactating women, PROTECT, Course, affected, reported, excluded, fetal, diabete, receive, obese patient, with COVID-19, 【제목키워드】 COVID-19 vaccination, women, pregnant, lactating,